Teva Launches Educational Initiative to Arm Women with Facts about Emergency Contraception
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Teva Pharma (TEVA) Comments on Stichting's Move to Exercise Call Option on Mylan (MYL); Sees as 'Unwarranted'
July 23, 2015 9:06 AM EDTTeva Pharma (NYSE: TEVA) issued the following statement regarding Stichting Preferred Shares Mylans (Nasdaq: MYL) decision to exercise its call option:
We strongly disagree with the stated analysis of Stichting Preferred Shares Mylan and its decision... More
